Product Name: Human VEGFB Antibody (CSL346, Research Use)
Catalog Number: NBR-0332
Target Name: VEGFB
Trade Name: CSL346
Antibody Drug Description: CSL346 is humanised monoclonal antibody targeting VEGF-B for the potential treatment of diabetic kidney disease (DKD). Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: VEGFB
Synonyms: VEGFL; VRF
Target Description: Growth factor for endothelial cells. VEGF-B167 binds heparin and neuropilin-1 whereas the binding to neuropilin-1 of VEGF-B186 is regulated by proteolysis.
Ensembl: ENSG00000173511
Uniprot: P49765